Compound Name (alphabetical) | Binding Targets | Enz. Inhib. Data | ITC Data | Alternate Compound Names |
---|
Ki | IC50 | Kd | EC50 | Koff | Kon | Other |
---|
BDBM103334
 | - Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Estradiol 17-beta-dehydrogenase 1 (17beta-HSD1)
- Estradiol 17-beta-dehydrogenase 2
| 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM103338
 | - Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Estradiol 17-beta-dehydrogenase 1 (17beta-HSD1)
- Estradiol 17-beta-dehydrogenase 2
| 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM103346
 | - Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Estradiol 17-beta-dehydrogenase 1 (17beta-HSD1)
- Estradiol 17-beta-dehydrogenase 2
| 0 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM103737
 | - JAK1 (aa 850-1154)
- JAK2 (aa 808-1132)
- JAK3 (aa 781-1124)
- Non-receptor tyrosine-protein kinase TYK2
- Tyrosine-protein kinase JAK1
- Tyrosine-protein kinase JAK2
- Tyrosine-protein kinase JAK3
| 0 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - US10206907, Compound 234
- US8563545, 11
|
BDBM103842
 | - D(2) dopamine receptor
- Histone Lysine Demethylase
- Homo sapiens lysine demethylase 2A (KDM2A)
- Jumonji domain-containing protein 2A (JMJD2A)
- Jumonji domain-containing protein 2C (JMJD2C)
- Lysine-specific demethylase 3A
- Lysine-specific demethylase 5C
| 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM103843
 | - D(2) dopamine receptor
- Histone Lysine Demethylase
- Homo sapiens lysine demethylase 2A (KDM2A)
- Jumonji domain-containing protein 2A (JMJD2A)
- Jumonji domain-containing protein 2C (JMJD2C)
- Lysine-specific demethylase 3A
- Lysine-specific demethylase 5C
| 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM103844
 | - D(2) dopamine receptor
- Histone Lysine Demethylase
- Homo sapiens lysine demethylase 2A (KDM2A)
- Jumonji domain-containing protein 2A (JMJD2A)
- Jumonji domain-containing protein 2C (JMJD2C)
- Lysine-specific demethylase 3A
- Lysine-specific demethylase 5C
| 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM103845
 | - D(2) dopamine receptor
- Histone Lysine Demethylase
- Homo sapiens lysine demethylase 2A (KDM2A)
- Jumonji domain-containing protein 2A (JMJD2A)
- Jumonji domain-containing protein 2C (JMJD2C)
- Lysine-specific demethylase 3A
- Lysine-specific demethylase 5C
| 0 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM10620
 | - Acetylcholinesterase
- Butyrylcholinesterase
- Butyrylcholinesterase (BChE)
- Butyrylcholinesterase (BuChE)
- Carboxylic ester hydrolase
- Cholinesterases
- Sodium-dependent serotonin transporter
| 4 | 88 | 0 | 0 | 0 | 0 | 0 | 0 | - (S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate
- 3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl N-methyl carbamate
- 3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate
- 3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate
- CHEMBL636
- ENA-713
- Ethyl-methyl-carbamic acid 3-((R)-1-dimethylamino-ethyl)-phenyl ester
- Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester
- Ethyl-methyl-carbamic acid 3-(1-dimethylamino-ethyl)-phenyl ester
- Exelon
- RIVASTIGMINE
- Rivastigmine
- Rivastigmine (1)
- SDZ-212-713
- SDZ-ENA-713
|
BDBM10750
 | - Acetylcholinesterase
- Amine oxidase (flavin-containing) A
- Amine oxidase [flavin-containing] B
- Butyrylcholinesterase (BChE)
- Cholinesterase
- Monoamine Oxidase Type B (MAO-B)
- Monoamine oxidase
| 2 | 19 | 0 | 0 | 0 | 0 | 0 | 0 | - (3R)-3-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-inden-5-yl N-ethyl-N-methylcarbamate hydrochloride
- Aminoindan deriv. (R)18b
- Aminoindan deriv. (R)18b.HCl
- N-propargylaminoindan (R)18b.HCl
- R-CPAI
|
BDBM108118
 | - Coagulation factor X
- Coagulation factor XI
- Complement C1s
- Plasma kallikrein
- Plasminogen
- Transcription initiation factor IIA
- Vitamin K-dependent protein C
| 8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM10826
 | - Acetylcholinesterase
- Amine oxidase (flavin-containing) A
- Amine oxidase [flavin-containing] B
- Butyrylcholinesterase (BChE)
- Cholinesterase
- Monoamine Oxidase Type B (MAO-B)
- Monoamine oxidase
| 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - 3-{2-[methyl(prop-2-yn-1-yl)amino]propyl}phenyl N-hexyl-N-methylcarbamate
- CHEMBL356385
- Phenethylamine deriv. 53d
|
BDBM10909
 | - CDK2/CycE
- Casein Kinase I
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 5 (CDK5)
- Dual-specificity tyrosine-phosphorylation regulated kinase 1A
- Mitogen-activated protein kinase 1
- Voltage-gated calcium channel subunit alpha Cav2.2
| 0 | 6 | 0 | 1 | 0 | 0 | 0 | 0 | - (2R)-2-({6-[benzyl(methyl)amino]-9-(propan-2-yl)-9H-purin-2-yl}amino)butan-1-ol
- N6-methyl-(R)-roscovitine
- R-2-[6-(Benzyl-methyl-amino)-9-isopropyl-9H-purin-2-ylamino]-butan-1-ol
|
BDBM11034
 | - Carbonic Anhydrase XIV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 7
- Carbonic anhydrase 9
- Carbonic anhydrases; II & IX
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - 1-pentafluorophenylamido-5-sulfonamidoindane
- 2,3,4,5,6-pentafluoro-N-(5-sulfamoyl-2,3-dihydro-1H-inden-1-yl)benzamide
- CHEMBL205867
- Indanesulfonamide Derivative 11c
|
BDBM112499
 | - Calmodulin/Proto-oncogene tyrosine-protein kinase Src
- Epidermal growth factor receptor
- Proto-oncogene tyrosine-protein kinase Src
- Receptor protein-tyrosine kinase erbB-4
- Receptor tyrosine-protein kinase erbB-2
- Tyrosine-protein kinase JAK3
- Tyrosine-protein kinase Lck
| 0 | 27 | 0 | 0 | 0 | 0 | 0 | 0 | - DACOMITINIB
- US8623883, No. 2
|
BDBM112780
 | - 5-hydroxytryptamine receptor 2B
- Adrenergic Alpha
- Bile salt export pump
- Canalicular multispecific organic anion transporter 1
- Canalicular multispecific organic anion transporter 2
- Multidrug resistance-associated protein 4
- Proto-oncogene tyrosine-protein kinase receptor Ret
| 1 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113060
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113065
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113067
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113068
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113069
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113119
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113248
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113283
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113292
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113293
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113294
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113295
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113296
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113297
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113299
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113300
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM113301
 | - Cathepsin G
- Chymotrypsin
- Kallikrein 14
- Kallikrein 5
- Kallikrein 7
- Prothrombin
- Trypsin-1
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
BDBM11605
 | - β-Carbonic anhydrase 2 (CA 2)
- β-Carbonic anhydrase 3 (CA 3)
- Carbonic Anhydrase (mtCA 1)
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Carbonic anhydrase 9
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - β-CA inhibitor, 4
- 4-Amino-5-chloro-3-fluorobenzenesulfonamide
- 4-amino-3-chloro-5-fluorobenzene-1-sulfonamide
- halogenosulfanilamide deriv. 6
|
BDBM11606
 | - β-Carbonic anhydrase 2 (CA 2)
- β-Carbonic anhydrase 3 (CA 3)
- Carbonic Anhydrase (mtCA 1)
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Carbonic anhydrase 9
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - β-CA inhibitor, 5
- 4-Amino-5-bromo-3-fluorobenzenesulfonamide
- 4-amino-3-bromo-5-fluorobenzene-1-sulfonamide
- halogenosulfanilamide deriv. 7
|
BDBM11608
 | - β-Carbonic anhydrase 2 (CA 2)
- β-Carbonic anhydrase 3 (CA 3)
- Carbonic Anhydrase (mtCA 1)
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Carbonic anhydrase 9
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - β-CA inhibitor, 7
- 4-Amino-3,5-dichlorobenzenesulfonamide
- 4-amino-3,5-dichlorobenzene-1-sulfonamide
- halogenosulfanilamide deriv. 9
|
BDBM11609
 | - β-Carbonic anhydrase 2 (CA 2)
- β-Carbonic anhydrase 3 (CA 3)
- Carbonic Anhydrase (mtCA 1)
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Carbonic anhydrase 9
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - β-CA inhibitor, 8
- 4-Amino-5-bromo-3-chlorobenzenesulfonamide
- 4-amino-3-bromo-5-chlorobenzene-1-sulfonamide
- halogenosulfanilamide deriv. 10
|
BDBM11610
 | - β-Carbonic anhydrase 2 (CA 2)
- β-Carbonic anhydrase 3 (CA 3)
- Carbonic Anhydrase (mtCA 1)
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Carbonic anhydrase 9
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - β-CA inhibitor, 9
- 4-Amino-3-chloro-5-iodobenzenesulfonamide
- 4-amino-3-chloro-5-iodobenzene-1-sulfonamide
- halogenosulfanilamide deriv. 11
|
BDBM11622
 | - β-Carbonic anhydrase 2 (CA 2)
- β-Carbonic anhydrase 3 (CA 3)
- Carbonic Anhydrase (mtCA 1)
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Carbonic anhydrase 9
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - β-CA inhibitor, 1
- 2-N-(4-amino-3-chlorobenzene)-1,3,4-thiadiazole-2,5-disulfonamide
- 5-(4-Amino-3-chlorobenzenesulfonamido)-1,3,4-thiadiazole-2-sulfonamide
- aminobenzolamide 17c
|
BDBM11626
 | - β-Carbonic anhydrase 2 (CA 2)
- β-Carbonic anhydrase 3 (CA 3)
- Carbonic Anhydrase (mtCA 1)
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Carbonic anhydrase 9
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - β-CA inhibitor, 2
- 2-N-(4-amino-3-bromo-5-fluorobenzene)-1,3,4-thiadiazole-2,5-disulfonamide
- 5-{[(4-amino-3-bromo-5-fluorophenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
- aminobenzolamide 19
|
BDBM11627
 | - β-Carbonic anhydrase 2 (CA 2)
- β-Carbonic anhydrase 3 (CA 3)
- Carbonic Anhydrase (mtCA 1)
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Carbonic anhydrase 9
| 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - β-CA inhibitor, 3
- 2-N-(4-amino-3-fluoro-5-iodobenzene)-1,3,4-thiadiazole-2,5-disulfonamide
- 5-{[(4-amino-3-fluoro-5-iodophenyl)sulfonyl]amino}-1,3,4-thiadiazole-2-sulfonamide
- aminobenzolamide 20
|
BDBM11635
 | - Astrosclerin-3
- Carbonic Anhydrase III
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 9
| 32 | 0 | 0 | 0 | 0 |